CA2155540A1 - Methodes pour traiter la sclerose laterale amyotrophique a l'aide de cntf - Google Patents

Methodes pour traiter la sclerose laterale amyotrophique a l'aide de cntf

Info

Publication number
CA2155540A1
CA2155540A1 CA 2155540 CA2155540A CA2155540A1 CA 2155540 A1 CA2155540 A1 CA 2155540A1 CA 2155540 CA2155540 CA 2155540 CA 2155540 A CA2155540 A CA 2155540A CA 2155540 A1 CA2155540 A1 CA 2155540A1
Authority
CA
Canada
Prior art keywords
cntf
day
als
patients
administered
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA 2155540
Other languages
English (en)
Inventor
Frank Collins
Mark Dietz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Syntex Synergen Neuroscience Joint Venture
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2155540A1 publication Critical patent/CA2155540A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/185—Nerve growth factor [NGF]; Brain derived neurotrophic factor [BDNF]; Ciliary neurotrophic factor [CNTF]; Glial derived neurotrophic factor [GDNF]; Neurotrophins, e.g. NT-3

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Psychology (AREA)
  • Neurology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA 2155540 1993-02-08 1994-02-03 Methodes pour traiter la sclerose laterale amyotrophique a l'aide de cntf Abandoned CA2155540A1 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US1521893A 1993-02-08 1993-02-08
US08/015,218 1993-02-08
US11644093A 1993-09-03 1993-09-03
US08/116,440 1993-09-03

Publications (1)

Publication Number Publication Date
CA2155540A1 true CA2155540A1 (fr) 1994-08-18

Family

ID=26687105

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2155540 Abandoned CA2155540A1 (fr) 1993-02-08 1994-02-03 Methodes pour traiter la sclerose laterale amyotrophique a l'aide de cntf

Country Status (4)

Country Link
EP (1) EP0682525A1 (fr)
AU (1) AU6169894A (fr)
CA (1) CA2155540A1 (fr)
WO (1) WO1994017818A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2220897A1 (fr) * 1995-05-12 1996-11-14 The Rockefeller University Traitement de la maladie d'alzheimer par modulation des synapsines
AU7204996A (en) * 1995-10-02 1997-04-28 Cytotherapeutics, Inc. Method for treating amyotrophic lateral sclerosis
AU8021098A (en) * 1997-06-13 1998-12-30 Roche Diagnostics Gmbh Improvement of the regeneration of myelin sheaths
WO2002006341A1 (fr) * 2000-07-14 2002-01-24 Children's Medical Center Corporation Facteur tropique capable de produire un effet salutaire sur le systeme nerveux chez un sujet
EP2558499B1 (fr) 2010-04-16 2017-04-12 Biogen MA Inc. Anticorps anti-vla-4

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4923696A (en) * 1987-05-04 1990-05-08 Baylor College Of Medicine Method to prepare a neurotrophic composition
US4997929A (en) * 1989-01-05 1991-03-05 Synergen, Inc. Purified ciliary neurotrophic factor
US5011914A (en) * 1989-01-05 1991-04-30 Collins Franklin D Purified ciliary neurotrophic factor
US5093317A (en) * 1989-06-05 1992-03-03 Cephalon, Inc. Treating disorders by application of insulin-like growth factor
IE903130A1 (en) * 1989-09-15 1991-03-27 Regeneron Pharma Ciliary neurotrophic factor

Also Published As

Publication number Publication date
AU6169894A (en) 1994-08-29
EP0682525A1 (fr) 1995-11-22
WO1994017818A1 (fr) 1994-08-18

Similar Documents

Publication Publication Date Title
US8207115B2 (en) Treatment of cartilage disorders with FGF-18
EP1993589B1 (fr) Traitements pour troubles neurologiques
JPH11147829A (ja) 疼痛を軽減し行動異常および知覚異常を治療するための 筋芽細胞導入療法
EP0639079A1 (fr) Methodes de traitement des maladies induites par l'interleukine-1 et le facteur de necrose tumorale
ES2392883T3 (es) Tratamiento de trastornos de cartílagos con FGF-18
CN115397443A (zh) 包含疼痛调节剂的干细胞来源的外排体及其用途
KR20130016127A (ko) 외상성 뇌손상의 치료
JP2019506439A (ja) ターゲティングされた治療用リソソーム酵素融合タンパク質、関連する製剤、およびその使用
PT792160E (pt) Factor neurotrofico derivado das celulas gliais utilizado como agente neuroprotector
JP2001512447A (ja) アミホスチンの投与方法
JP2003520237A (ja) 鬱病及び関連疾患を治療するためのミルトラザピン及びジェピロンを含有する配合剤
CA2155540A1 (fr) Methodes pour traiter la sclerose laterale amyotrophique a l'aide de cntf
Tsao et al. The childhood muscular dystrophies: making order out of chaos
Tomlinson et al. Proximal myopathy after perhexiline maleate treatment.
US6143714A (en) Methods of using hepatocyte growth factor to promote survival, growth and differentiation of motor neurons
JP2009504636A (ja) 血漿または血清を含む神経損傷治療用の医薬組成物
US11969522B2 (en) Use of immune modulators to improve nerve regeneration
JP7350019B2 (ja) 筋萎縮性側索硬化症（ａｌｓ）を治療するための組成物、及び治療のためにそれを使用する方法
US5691313A (en) Methods of treating impotency with ciliary neurotrophic factor
EP1161441A1 (fr) Compositions favorisant la regeneration des tissus nerveux
US20220362219A1 (en) Retina regeneration through epigenetics manipulation
KR20230142502A (ko) 골관절염 통증 치료를 위한 link-tsg6의 용도
JP2023525256A (ja) 脊髄性筋萎縮症を治療する方法及び薬剤
WO2019032469A1 (fr) Traitement du surpoids et de l'obésité associés à une déficience en leptine
US20050049196A1 (en) Indirect delivery of growth factors into the central nervous system

Legal Events

Date Code Title Description
FZDE Dead